Efficacy and Safety of Mometasone Furoate/Formoterol in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease: Results From Two Phase Three 26-Week Trials

Pulmonary Disease ◽

Mometasone Furoate ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Two Phase ◽

Clinical Efficacy and Safety of Combined Mometasone Furoate and Formoterol in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD)

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2011.12.176 ◽

2012 ◽

Vol 129 (2) ◽

pp. AB201

Author(s):

E. Kerwin ◽

D.P. Tashkin ◽

C.E. Matiz-Bueno ◽

D.E. Doherty ◽

T. Shekar ◽

...

Keyword(s):

Pulmonary Disease ◽

Clinical Efficacy ◽

Mometasone Furoate ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Combined Mometasone Furoate and Formoterol in Patients With Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD): Phase 3 Efficacy and Safety Study

Journal of Allergy and Clinical Immunology ◽

10.1016/j.jaci.2011.12.605 ◽

2012 ◽

Vol 129 (2) ◽

pp. AB75

Author(s):

D.E. Doherty ◽

E. Kerwin ◽

D.P. Tashkin ◽

C.E. Matiz-Bueno ◽

T. Shekar ◽

...

Keyword(s):

Pulmonary Disease ◽

Mometasone Furoate ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Safety Study ◽

Phase 3 ◽

The Effect of Mometasone Furoate/Formoterol Combination Therapy on Chronic Obstructive Pulmonary Disease (COPD) Exacerbations: Results From Two Phase Three Trials in Subjects With Moderate to Very Severe COPD

CHEST Journal ◽

10.1378/chest.1119324 ◽

2011 ◽

Vol 140 (4) ◽

pp. 549A ◽

Cited By ~ 2

Author(s):

Donald Tashkin ◽

Dennis Doherty ◽

Edward Kerwin ◽

Carlos Eduardo Matiz-Bueno ◽

Tulin Shekar ◽

...

Keyword(s):

Combination Therapy ◽

Pulmonary Disease ◽

Mometasone Furoate ◽

Chronic Obstructive ◽

Two Phase ◽

Copd Exacerbations ◽

Severe Copd

Quality of Life Following 26 Weeks of Mometasone Furoate/Formoterol Therapy: Results From Two Phase Three Trials in Subjects With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

CHEST Journal ◽

10.1378/chest.1119155 ◽

2011 ◽

Vol 140 (4) ◽

pp. 558A ◽

Cited By ~ 2

Author(s):

Edward Kerwin ◽

Donald Tashkin ◽

Carlos Eduardo Matiz-Bueno ◽

Dennis Doherty ◽

Tulin Shekar ◽

...

Keyword(s):

Quality Of Life ◽

Pulmonary Disease ◽

Mometasone Furoate ◽

Chronic Obstructive ◽

Two Phase ◽

Supervised physical exercise training for chronic obstructive pulmonary disease: long-term efficacy and safety

10.1002/14651858.cd006906 ◽

2008 ◽

Author(s):

Rachel Garrod ◽

Dina Brooks ◽

Toby J Lasserson ◽

E. Haydn Walters ◽

Amanda Thomson

Keyword(s):

Exercise Training ◽

Physical Exercise ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Term Efficacy ◽

Physical Exercise Training

Bayesian Network Meta-Analysis To Assess The Comparative Efficacy And Safety Of Treatments For Chronic Obstructive Pulmonary Disease

Value in Health ◽

10.1016/j.jval.2015.09.1383 ◽

2015 ◽

Vol 18 (7) ◽

pp. A495

Author(s):

V Taieb ◽

D Belhadi ◽

AT Nielsen ◽

M Hemels ◽

J Van Laer

Keyword(s):

Bayesian Network ◽

Pulmonary Disease ◽

Meta Analysis ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Comparative Efficacy ◽

Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial

The Lancet Respiratory Medicine ◽

10.1016/s2213-2600(13)70200-5 ◽

2014 ◽

Vol 2 (1) ◽

pp. 63-72 ◽

Cited By ~ 51

Author(s):

Henrik Watz ◽

Helen Barnacle ◽

Benjamin F Hartley ◽

Robert Chan

Keyword(s):

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

P38 Mapk Inhibitor ◽

Mapk Inhibitor

A Comparison of Tiotropium 18µg, Once Daily and Ipratropium 40µg, 4 Times Daily in a Double-Blind, Double-Dummy, Efficacy and Safety Study in Adults with Chronic Obstructive Pulmonary Disease

Tuberculosis and Respiratory Diseases ◽

10.4046/trd.2005.58.5.498 ◽

2005 ◽

Vol 58 (5) ◽

pp. 498 ◽

Cited By ~ 4

Author(s):

Seung Joon Kim ◽

Myung Sook Kim ◽

Sang Haak Lee ◽

Young Kyoon Kim ◽

Hwa Sik Moon ◽

...

Keyword(s):

Pulmonary Disease ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Safety Study ◽

Double Blind ◽

Once Daily

Efficacy and safety of Xuebijing injection and its influence on immunomodulation in acute exacerbations of chronic obstructive pulmonary disease: study protocol for a randomized controlled trial

Trials ◽

10.1186/s13063-019-3204-z ◽

2019 ◽

Vol 20 (1) ◽

Cited By ~ 1

Author(s):

Sheling Xie ◽

Peng Yan ◽

Chen Yao ◽

Xiaoyan Yan ◽

Yuliang Huo ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Pulmonary Disease ◽

Controlled Trial ◽

Chronic Obstructive ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Acute Exacerbations ◽

Disease Study

Response to: Oba, Y. and Lone, N. (2013) Efficacy and safety of roflumilast in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis.Ther Adv Respir Dis 7: 13–24.

Therapeutic Advances in Respiratory Disease ◽

10.1177/1753465813489767 ◽

2013 ◽

Vol 7 (4) ◽

pp. 247-249 ◽

Cited By ~ 1

Author(s):

Shahid Siddiqui

Keyword(s):

Systematic Review ◽

Pulmonary Disease ◽

Chronic Obstructive ◽

Efficacy And Safety ◽